-
Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH, 2010: PHENIX: a comprehensive python-based system for macromolecular structure solution[J]. Acta Crystallogr D Biol Crystallogr, 66, 213-221. doi: 10.1107/S0907444909052925
-
Ayouni S, Sdiri-Loulizi K, de Rougemont A, Estienney M, Ambert-Balay K, Aho S, Hamami S, Aouni M, Neji-Guediche M, Pothier P, Belliot G, 2015: Rotavirus P[8] infections in persons with secretor and nonsecretor phenotypes, Tunisia[J]. Emerg Infect Dis, 21, 2055-2058. doi: 10.3201/eid2111.141901
-
Barbe L, Le Moullac-Vaidye B, Echasserieau K, Bernardeau K, Carton T, Bovin N, Nordgren J, Svensson L, Ruvoen-Clouet N, Le Pendu J, 2018: Histo-blood group antigen-binding specificities of human rotaviruses are associated with gastroenteritis but not with in vitro infection[J]. Sci Rep, 8, 12961-. doi: 10.1038/s41598-018-31005-4
-
Blanchard H, Yu X, Coulson BS, von Itzstein M, 2007: Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*)[J]. J Mol Biol, 367, 1215-1226. doi: 10.1016/j.jmb.2007.01.028
-
Bohm R, Fleming FE, Maggioni A, Dang VT, Holloway G, Coulson BS, von Itzstein M, Haselhorst T, 2015: Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion[J]. Nat Commun, 6, 5907-. doi: 10.1038/ncomms6907
-
Burnett E, Parashar U, Tate J, 2018: Rotavirus vaccines: effectiveness, safety, and future directions[J]. Paediatr Drugs, 20, 223-233. doi: 10.1007/s40272-018-0283-3
-
Ciarlet M, Estes MK, 1999: Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity[J]. J Gen Virol, 80, 943-948.
-
Desselberger U, 2017: Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors[J]. Pathogens, , -. doi: 10.3390/pathogens6040065
-
Dormitzer PR, Sun ZY, Wagner G, Harrison SC, 2002: The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site[J]. EMBO J, 21, 885-897. doi: 10.1093/emboj/21.5.885
-
Emsley P, Cowtan K, 2004: Coot: model-building tools for molecular graphics[J]. Acta Crystallogr D Biol Crystallogr, 60, 2126-2132. doi: 10.1107/S0907444904019158
-
Estes MK, Greenberg HB (2013) Rotaviruses. In: Knipe DM, Howley PM et al (eds) Fields Virology, 6th edn. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, pp 1347-1401
-
Etzold S, Bode L, 2014: Glycan-dependent viral infection in infants and the role of human milk oligosaccharides[J]. Curr Opin Virol, 7, 101-107. doi: 10.1016/j.coviro.2014.06.005
-
Fiore L, Greenberg HB, Mackow ER, 1991: The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin[J]. Virology, 181, 553-563. doi: 10.1016/0042-6822(91)90888-I
-
Fleming FE, Bohm R, Dang VT, Holloway G, Haselhorst T, Madge PD, Deveryshetty J, Yu X, Blanchard H, von Itzstein M, Coulson BS, 2014: Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection[J]. J Virol, 88, 4558-4571. doi: 10.1128/JVI.03431-13
-
Gunaydin G, Nordgren J, Sharma S, Hammarstrom L, 2016: Association of elevated rotavirus-specific antibody titers with HBGA secretor status in Swedish individuals: the FUT2 gene as a putative susceptibility determinant for infection[J]. Virus Res, 211, 64-68. doi: 10.1016/j.virusres.2015.10.005
-
Haselhorst T, Fleming FE, Dyason JC, Hartnell RD, Yu X, Holloway G, Santegoets K, Kiefel MJ, Blanchard H, Coulson BS, von Itzstein M, 2009: Sialic acid dependence in rotavirus host cell invasion[J]. Nat Chem Biol, 5, 91-93. doi: 10.1038/nchembio.134
-
Hu L, Crawford SE, Czako R, Cortes-Penfield NW, Smith DF, Le Pendu J, Estes MK, Prasad BV, 2012: Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen[J]. Nature, 485, 256-259. doi: 10.1038/nature10996
-
Hu L, Ramani S, Czako R, Sankaran B, Yu Y, Smith DF, Cummings RD, Estes MK, Venkataram Prasad BV, 2015: Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus[J]. Nat Commun, 6, 8346-. doi: 10.1038/ncomms9346
-
Hu L, Sankaran B, Laucirica DR, Patil K, Salmen W, Ferreon ACM, Tsoi PS, Lasanajak Y, Smith DF, Ramani S, Atmar RL, Estes MK, Ferreon JC, Prasad BVV, 2018: Glycan recognition in globally dominant human rotaviruses[J]. Nat Commun, 9, 2631-. doi: 10.1038/s41467-018-05098-4
-
Huang P, Xia M, Tan M, Zhong W, Wei C, Wang L, Morrow A, Jiang X, 2012: Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner[J]. J Virol, 86, 4833-4843. doi: 10.1128/JVI.05507-11
-
Imbert-Marcille BM, Barbe L, Dupe M, Le Moullac-Vaidye B, Besse B, Peltier C, Ruvoen-Clouet N, Le Pendu J, 2014: A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype[J]. J Infect Dis, 209, 1227-1230. doi: 10.1093/infdis/jit655
-
Jensen PH, Kolarich D, Packer NH, 2010: Mucin-type O-glycosylation—putting the pieces together[J]. FEBS J, 277, 81-94. doi: 10.1111/j.1742-4658.2009.07429.x
-
Jiang X, Liu Y, Tan M, 2017: Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy[J]. Emerg Microbes Infect, 6, e22-.
-
Johannes M, Reindl M, Gerlitzki B, Schmitt E, Hoffmann-Roder A, 2015: Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4′-deoxy-4′-fluoro-Thomsen-Friedenreich epitope[J]. Beilstein J Org Chem, 11, 155-161.
-
Kuhlenschmidt TB, Hanafin WP, Gelberg HB, Kuhlenschmidt MS, 1999: Sialic acid dependence and independence of group A rotaviruses[J]. Adv Exp Med Biol, 473, 309-317.
-
Kunz C, Rudloff S, Baier W, Klein N, Strobel S, 2000: Oligosaccharides in human milk: structural, functional, and metabolic aspects[J]. Annu Rev Nutr, 20, 699-722.
-
Liu Y, Huang P, Tan M, Liu Y, Biesiada J, Meller J, Castello AA, Jiang B, Jiang X, 2012: Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens[J]. J Virol, 86, 9899-9910. doi: 10.1128/JVI.00979-12
-
Liu Y, Huang P, Jiang B, Tan M, Morrow AL, Jiang X, 2013: Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants[J]. PLoS ONE, 8, e78113-. doi: 10.1371/journal.pone.0078113
-
Liu Y, Ramelot TA, Huang P, Liu Y, Li Z, Feizi T, Zhong W, Wu FT, Tan M, Kennedy MA, Jiang X, 2016: Glycan specificity of P[19] rotavirus and comparison with those of related P genotypes[J]. J Virol, 90, 9983-9996. doi: 10.1128/JVI.01494-16
-
Liu Y, Xu S, Woodruff AL, Xia M, Tan M, Kennedy MA, Jiang X, 2017: Structural basis of glycan specificity of P[19] VP8*: implications for rotavirus zoonosis and evolution[J]. PLoS Pathog, 13, e1006707-. doi: 10.1371/journal.ppat.1006707
-
Ma X, Li DD, Sun XM, Guo YQ, Xiang JY, Wang WH, Zhang LX, Gu QJ, Duan ZJ, 2015: Binding patterns of rotavirus genotypes P[4], P[6], and P[8] in China with histo-blood group antigens[J]. PLoS ONE, 10, e0134584-. doi: 10.1371/journal.pone.0134584
-
Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR, Buesa J, Esona MD, Estes MK, Gentsch JR, Iturriza-Gomara M, Johne R, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Parreno V, Rahman M, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Patton JT, Desselberger U, Van Ranst M, 2011: Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG)[J]. Arch Virol, 156, 1397-1413. doi: 10.1007/s00705-011-1006-z
-
Moran AP, Gupta A, Joshi L, 2011: Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract[J]. Gut, 60, 1412-1425. doi: 10.1136/gut.2010.212704
-
Morozov V, Hansman G, Hanisch FG, Schroten H, Kunz C, 2018: Human milk oligosaccharides as promising antivirals[J]. Mol Nutr Food Res, 62, e1700679-. doi: 10.1002/mnfr.201700679
-
Nordgren J, Sharma S, Bucardo F, Nasir W, Gunaydin G, Ouermi D, Nitiema LW, Becker-Dreps S, Simpore J, Hammarstrom L, Larson G, Svensson L, 2014: Both lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype dependent manner[J]. Clin Infect Dis, 59, 1567-1573. doi: 10.1093/cid/ciu633
-
Otwinowski Z, Minor W, 1997: Processing of X-ray diffraction data collected in oscillation mode[J]. Macromol Crystallogr Pt A, 276, 307-326. doi: 10.1016/S0076-6879(97)76066-X
-
Pang LL, Wang MX, Sun XM, Yuan Y, Qing Y, Xin Y, Zhang JY, Li DD, Duan ZJ, 2018: Glycan binding patterns of human rotavirus P[10] VP8* protein[J]. Virol J, 15, 161-. doi: 10.1186/s12985-018-1065-9
-
Pindyck T, Tate JE, Parashar UD, 2018: A decade of experience with rotavirus vaccination in the United States—vaccine uptake, effectiveness, and impact[J]. Expert Rev Vaccines, 17, 593-606. doi: 10.1080/14760584.2018.1489724
-
Pollock L, Bennett A, Jere KC, Dube Q, Mandolo J, Bar-Zeev N, Heyderman RS, Cunliffe NA, Iturriza-Gomara M, 2018: Non-secretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in Malawian infants[J]. Clin Infect Dis, , -. doi: 10.1093/cid/ciy1067
-
Ramani S, Cortes-Penfield NW, Hu L, Crawford SE, Czako R, Smith DF, Kang G, Ramig RF, Le Pendu J, Prasad BV, Estes MK, 2013: The VP8* domain of neonatal rotavirus strain G10P[11] binds to type Ⅱ precursor glycans[J]. J Virol, 87, 7255-7264. doi: 10.1128/JVI.03518-12
-
Ramani S, Stewart CJ, Laucirica DR, Ajami NJ, Robertson B, Autran CA, Shinge D, Rani S, Anandan S, Hu L, Ferreon JC, Kuruvilla KA, Petrosino JF, Venkataram Prasad BV, Bode L, Kang G, Estes MK, 2018: Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection[J]. Nat Commun, 9, 5010-. doi: 10.1038/s41467-018-07476-4
-
Read RJ, 2001: Pushing the boundaries of molecular replacement with maximum likelihood[J]. Acta Crystallogr D Biol Crystallogr, 57, 1373-1382. doi: 10.1107/S0907444901012471
-
Rey FA, Gozalbo-Rovira R, Ciges-Tomas JR, Vila-Vicent S, Buesa J, Santiso-Bellón C, Monedero V, Yebra MJ, Marina A, Rodríguez-Díaz J, 2019: Unraveling the role of the secretor antigen in human rotavirus attachment to histo-blood group antigens[J]. PLoS Pathog, 15, e1007865-. doi: 10.1371/journal.ppat.1007865
-
Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD, 2014: Effectiveness and impact of rotavirus vaccines in the United States—2006-2012[J]. Expert Rev Vaccines, 13, 365-376. doi: 10.1586/14760584.2014.877846
-
Ruggeri FM, Greenberg HB, 1991: Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture[J]. J Virol, 65, 2211-2219. doi: 10.1128/JVI.65.5.2211-2219.1991
-
Skovlund VR, 1997: ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors[J]. APMIS Suppl, 69, 1-33.
-
Sun X, Guo N, Li D, Jin M, Zhou Y, Xie G, Pang L, Zhang Q, Cao Y, Duan ZJ, 2016a: Binding specificity of P[8] VP8* proteins of rotavirus vaccine strains with histo-blood group antigens[J]. Virology, 495, 129-135. doi: 10.1016/j.virol.2016.05.010
-
Sun X, Guo N, Li J, Yan X, He Z, Li D, Jin M, Xie G, Pang L, Zhang Q, Liu N, Duan ZJ, 2016b: Rotavirus infection and histo-blood group antigens in the children hospitalized with diarrhoea in China[J]. Clin Microbiol Infect, 22, e741-e743.
-
Sun X, Guo N, Li J, Yan X, He Z, Li D, Jin M, Xie G, Pang L, Zhang Q, Liu N, Duan ZJ, 2016c: Rotavirus infection and histo-blood group antigens in the children hospitalized with diarrhoea in China[J]. Clin Microbiol Infect, , -. doi: 10.1016/j.cmi.2016.06.007
-
Sun X, Li D, Peng R, Guo N, Jin M, Zhou Y, Xie G, Pang L, Zhang Q, Qi J, Duan ZJ, 2016d: Functional and structural characterization of P[19] rotavirus VP8* Interaction with histo-blood group antigens[J]. J Virol, 90, 9758-9765. doi: 10.1128/JVI.01566-16
-
Sun X, Li D, Qi J, Chai W, Wang L, Wang L, Peng R, Wang H, Zhang Q, Pang L, Kong X, Wang H, Jin M, Gao GF, Duan Z, 2018: Glycan binding specificity and mechanism of human and porcine P[6]/P[19] rotavirus VP8*s[J]. J Virol, 92, e00538-18.
-
Tan M, Jiang X, 2014: Histo-blood group antigens: a common niche for norovirus and rotavirus[J]. Expert Rev Mol Med, 16, e5-. doi: 10.1017/erm.2014.2
-
Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization-Coordinated Global Rotavirus Surveillance N (2016) Global, regional, and national estimates of rotavirus mortality in children < 5 years of age, 2000-2013. Clin Infect Dis 62(Suppl 2): S96-S105
-
Van Trang N, Vu HT, Le NT, Huang P, Jiang X, Anh DD, 2014: Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children[J]. J Clin Microbiol, 52, 1366-1374. doi: 10.1128/JCM.02927-13
-
Xu S, Liu Y, Tan M, Zhong W, Zhao D, Jiang X, Kennedy MA (2019) Molecular basis of P[6] and P[8] major human rotavirus VP8* domain interactions with histo-blood group antigens. BioRxiv. https://doi.org/10.1101/512301:512301
-
Yu Y, Lasanajak Y, Song X, Hu L, Ramani S, Mickum ML, Ashline DJ, Prasad BV, Estes MK, Reinhold VN, Cummings RD, Smith DF, 2014: Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses[J]. Mol Cell Proteom, 13, 2944-2960. doi: 10.1074/mcp.M114.039875
-
Yu J, Lai S, Geng Q, Ye C, Zhang Z, Zheng Y, Wang L, Duan Z, Zhang J, Wu S, Parashar U, Yang W, Liao Q, Li Z (2018) Prevalence of rotavirus and rapid changes in circulating rotavirus strains among children with acute diarrhea in China, 2009-2015. J Infect. https://doi.org/10.1016/j.jinf.2018.07.004
-
Zhang XF, Long Y, Tan M, Zhang T, Huang Q, Jiang X, Tan WF, Li JD, Hu GF, Tang S, Dai YC, 2016: P[8] and P[4] rotavirus infection associated with secretor phenotypes among children in South China[J]. Sci Rep, 6, 34591-. doi: 10.1038/srep34591